SCHEMBL6262441

SCHEMBL6262441

CC1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 4/20 0.56
▸ SNCA P37840 3/20 0.56
▸ ALOX15 P16050 3/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ MMP2 P08253 4/20 0.55
▸ MMP9 P14780 4/20 0.55
▸ XDH P47989 1/20 0.55
▸ PRKD3 O94806 1/20 0.55
▸ PRKCG P05129 1/20 0.55
▸ PRKCB P05771 1/20 0.55
▸ PRKCA P17252 1/20 0.55
▸ PRKCH P24723 1/20 0.55
▸ PRKCI P41743 1/20 0.55
▸ PRKCE Q02156 1/20 0.55
▸ PRKCQ Q04759 1/20 0.55
▸ PRKCZ Q05513 1/20 0.55
▸ PRKCD Q05655 1/20 0.55
▸ PRKD1 Q15139 1/20 0.55
▸ KDM4E B2RXH2 5/20 0.54
▸ BACE1 P56817 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2433863 1.00 HSD17B10 (0.56) HSD17B10SNCAALOX15CYP1A2MMP2
SCHEMBL6262437 1.00 HSD17B10 (0.56) HSD17B10SNCAALOX15CYP1A2MMP2
SCHEMBL1975182 0.87 HSD17B10 (0.44) HSD17B10SNCAALOX15CYP1A2MMP2
SCHEMBL21122054 0.87 PRKD3 (0.71) HSD17B10SNCAALOX15CYP1A2MMP2
Leucocianidol SCHEMBL1649595 0.86 XDH (0.74) HSD17B10SNCAALOX15CYP1A2MMP2
Leucocianidol SCHEMBL14339444 0.86 XDH (0.74) HSD17B10SNCAALOX15CYP1A2MMP2
Leucocianidol SCHEMBL31626217 0.86 XDH (0.74) HSD17B10SNCAALOX15CYP1A2MMP2
Leucocianidol SCHEMBL2298829 0.86 XDH (0.74) HSD17B10SNCAALOX15CYP1A2MMP2
Leucocianidol SCHEMBL28822447 0.86 XDH (0.74) HSD17B10SNCAALOX15CYP1A2MMP2
Leucocianidol SCHEMBL285598 0.86 XDH (0.74) HSD17B10SNCAALOX15CYP1A2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076841-B1 BONDED ABRASIVE ARTICLE AND METHOD OF MAKING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-01-31 — — EP claimed
EP-0933107-B1 Process for refining heat-deteriorative compound, contained in multi-component liquid mixture, by distillation UBE INDUSTRIES (JP) 2005-10-26 — — EP claimed
US-12233101-B2 Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and other diseases or symptoms NATUREX INC. (US) 2025-02-25 — — US disclosed
EP-3782634-B1 COMPOSITIONS FOR USES IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND OTHER DISEASES OR SYMPTOMS GIVAUDAN SA (CH) 2024-03-20 — — EP disclosed
CN-115778943-A Application of fraxins in resisting coronavirus 上海科技大学 2023-03-14 — — CN disclosed
CN-115645393-A Application of dihydromyricetin in resisting coronavirus 上海科技大学 2023-01-31 — — CN disclosed
CN-115581692-A Application of active component of lignum sappan in resisting coronavirus 上海科技大学 2023-01-10 — — CN disclosed
CN-115569196-A Application of polyphenol substances in resisting coronavirus 上海科技大学 2023-01-06 — — CN disclosed
CN-115569135-A Application of Tedberg in resisting coronavirus 上海科技大学 2023-01-06 — — CN disclosed
CN-115252610-A Application of proton pump inhibitor in resisting coronavirus 上海科技大学 2022-11-01 — — CN disclosed
US-20220175863-A1 COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION, AND OTHER DISEASES OR SYMPTOMS NATUREX INC. 2022-06-09 — — US disclosed
EP-0261385-B1 VEHICLE COMBINATION CURABLE BY CURING AGENTS, FOR USE IN AQUEOUS DILUTABLE COATINGS, CATHODICALLY DEPOSITABLE ELECTROPHORETIC COATING COMPOSITIONS, AND THEIR USE Herberts Gesellschaft mit beschränkter Haftung (DE) 1992-04-15 — — EP disclosed
EP-0180051-B1 PROCESS FOR THE PRODUCTION OF AN EXTERNALLY CROSS-LINKABLE EPOXY-FREE AMINO-POLY(METH)ACRYLATE RESIN, THE RESIN OBTAINABLE THEREBY, ITS USE, CATHODIC ELECTRODEPOSITION BATH CONTAINING IT AND ITS USE IN THE COATING OF OBJECTS Herberts Gesellschaft mit beschränkter Haftung (DE) 1990-04-04 — — EP disclosed
EP-0178531-B1 AQUEOUS ELECTRODIP-LACQUERING COATING COMPOSITION AND ITS USE IN COATING OBJECTS Herberts Gesellschaft mit beschränkter Haftung (DE) 1989-01-18 — — EP disclosed
EP-0287089-A2 Method for the manufacture of aqueous cathodically depositable electrodip lacquers Herberts Gesellschaft mit beschränkter Haftung (DE) 1988-10-19 — — EP disclosed
EP-0261385-A2 Vehicle combination curable by curing agents, for use in aqueous dilutable coatings, cathodically depositable electrophoretic coating compositions, and their use Herberts Gesellschaft mit beschränkter Haftung (DE) 1988-03-30 — — EP disclosed
EP-0260448-A2 Externally cross-linkable binder combination, aqueous coating compositions containing it and its use Herberts Gesellschaft mit beschränkter Haftung (DE) 1988-03-23 — — EP disclosed
EP-0259647-A2 Externally cross-linkable binder combination, aqueous coating compositions containing it and its use Herberts Gesellschaft mit beschränkter Haftung (DE) 1988-03-16 — — EP disclosed
EP-0180051-A1 Process for the production of an externally cross-linkable epoxy-free amino-poly(meth)acrylate resin, the resin obtainable thereby, its use, cathodic electrodeposition bath containing it and its use in the coating of objects Herberts Gesellschaft mit beschränkter Haftung (DE) 1986-05-07 — — EP disclosed
EP-0178531-A1 Aqueous electrodip-lacquering coating composition and its use in coating objects Herberts Gesellschaft mit beschränkter Haftung (DE) 1986-04-23 — — EP disclosed
Send feedback